EpiVax receives $150,000 in phase II funding from Slater Center for Bio-Technology by epivax3 | Mar 25, 2003 | News | 0 comments Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Currently you have JavaScript disabled. In order to post comments, please make sure JavaScript and Cookies are enabled, and reload the page. Click here for instructions on how to enable JavaScript in your browser.
